Interesting news from the US. So the regulatory bar is not being lowered, even though there is strong political will to increase the use of AI. As the agency faces backlogs and resource constraints, players that already hold FDA clearances for autonomous imaging and have solutions specifically targeting the care gap in rural areas are in a very strong position compared to new entrants.
10 Likes